RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW
RXIIW was delisted on the 16th of November, 2018.
4 hedge funds and large institutions have $904K invested in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less capital invested
Capital invested by funds: $1.8M → $904K (-$896K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.3M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.24M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$288K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$17.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $715K | -$1.3M | -1,999,549 | -90% |
|
|
CH
2
CVI Holdings
Wilmington,
Delaware
| $100K | +$144K | +221,686 | New |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $88K | -$1.24M | -1,904,275 | -91% |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | -$17.6K | -27,000 | -90% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$288K | -2,216,855 | Closed |
|
RXIIW Hedge Fund Activity: Q1 2018 in Review
4 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) for Q1 2018, worth a combined $904K — down 50% from $1.8M a quarter earlier.
Fund positioning in RXIIW was balanced in Q1 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 3 trimmed.
The largest seller was Anson Funds Management, cutting an estimated $1.3M.
- 4 institutional investors held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) as of Q1 2018, unchanged from Q4 2017.
- Funds reported $904K of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 stock for Q1 2018, down 50% quarter-over-quarter.
- 1 fund opened new RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 positions in Q1 2018 and 1 closed out, a net change of 0 holders.
- The largest RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 seller in Q1 2018 was Anson Funds Management, an estimated $1.3M sold.
Based on aggregated 13F filings for Q1 2018.